Save the Date image with dates Aug 12 to 14th 2022
Save the Date image with dates Aug 12 to 14th 2022

Announcing the Return of Psychedemia!

March 9, 2022By Psychedemia

Psychedemia is returning after 10 years at a critical time for the field of Psychedelic Studies. CEOs and thought leaders are promoting psychedelic medicines as singular tools to end the mental health crisis. We are of the opinion that psychedelic medicines will only realize their potential when human rights and environmental justice are centered in the discussion.

These themes are especially important to foreground given the current pace of medicalization: the FDA has granted breakthrough treatment status to two separate psychedelic therapies using MDMA and psilocybin for PTSD and treatment-resistant depression, respectively. Given that the “psychedelic drugs market” is projected to reach $10.75 billion by 2027 (PR Newswire 2021), with the potential for psychedelic medical corporations to scale globally and monopolize market share, much is at stake for clinical trials and their public interpretations in the popular media.

We believe that rigorous academic perspectives are necessary in order to build a post-prohibition world that works for all of us.

Join us this August for an interdisciplinary conference. We encourage contributions from all disciplinary perspectives and career stages.